Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01457885
What this trial is testing

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

Who this might be right for
Acute Myeloblastic Leukemia
University of Michigan Rogel Cancer Center 75
Testing effectiveness (Phase 2)Looking for participantsNCT06453460
What this trial is testing

CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT

Who this might be right for
CMVAllogeneic Stem Cell Transplantation
University of California, Irvine 50
Testing effectiveness (Phase 2)Looking for participantsNCT07359859
What this trial is testing

Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant

Who this might be right for
Hematologic Malignancies
Memorial Sloan Kettering Cancer Center 40
Not applicableUnknownNCT06491719
What this trial is testing

A Study on Efficacy and Safety of iNK Cells for CAEBV /EBV-HLH After Allo-HSCT

Who this might be right for
CAEBV (Chronic Active Epstein-Barr Virus Infection) SyndromeEBVHemophagocytic Lymphohistiocytoses
Beijing Friendship Hospital 15
Not applicableActive Not RecruitingNCT00959140
What this trial is testing

Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Related Donors

Who this might be right for
Hematopoietic Stem Cell Transplantation
University of Alabama at Birmingham 20
Not applicableStudy completedNCT01687231
What this trial is testing

Infection Rates of Myeloablative Allo SCT Recipients Receiving Neutropenic Diets Versus Non-Neutropenic Diets

Who this might be right for
Hematologic Malignancies
Duke University 47
Early research (Phase 1)Study completedNCT01926899
What this trial is testing

Phase I Study Evaluating the Addition of Bortezomib to an Established Acute Graft Versus Host Disease Prophylaxis Regimen in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients

Who this might be right for
Hematopoetic Stem Cell Transplant
Indiana University 15
Not applicableUnknownNCT05532826
What this trial is testing

Clinical Study of Donor EBV-CTL Infusion in Patients With CAEBV and EBV-HLH After Allo-HSCT

Who this might be right for
Chronic Active Epstein-Barr Virus InfectionVirus-Associated Hemophagocytic Syndrome
Beijing Friendship Hospital 15
Testing effectiveness (Phase 2)Ended earlyNCT02993783
What this trial is testing

A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Millennium Pharmaceuticals, Inc. 17
Not applicableEnrolling By InvitationNCT06864598
What this trial is testing

The Application of Novel Identified CD8 Regulatory Precursors in Inducing Immune Tolerance After Allo-HSCT

Who this might be right for
Graft-versus-host Disease (GVHD)
Peking University People's Hospital 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06861348
What this trial is testing

Effectiveness and Safety of InO±DLI for Relapsed B-ALL/LBL After Allo-HSCT

Who this might be right for
Leukemia, Lymphocytic, Acute
First Affiliated Hospital of Zhejiang University 23
Not applicableStudy completedNCT02604420
What this trial is testing

Identification and Treatment of Thrombotic Microangiopathies in Allogeneic Stem Cell Transplants

Who this might be right for
Thrombotic MicroangiopathyDisorder Related to Bone Marrow Transplantation
Weill Medical College of Cornell University 200
Early research (Phase 1)Ended earlyNCT03151057
What this trial is testing

Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies

Who this might be right for
B Cells-TumorsB Cell Chronic Lymphocytic LeukemiaFollicular Lymphoma+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 16
Testing effectiveness (Phase 2)Study completedNCT05009719
What this trial is testing

Risk-adapted Donor Lymphocyte Infusion After Allo-HSCT in Children With Hematologic Malignancy

Who this might be right for
Hematologic Malignancy
St. Petersburg State Pavlov Medical University 50
Testing effectiveness (Phase 2)UnknownNCT05143892
What this trial is testing

Avatrombopag to Promote Platelet Engraftment After Allo-HSCT

Who this might be right for
Platelet Disorder
The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)Study completedNCT02497404
What this trial is testing

Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR

Who this might be right for
Leukemia, Erythroblastic, AcuteMyelodysplastic Syndromes
Weill Medical College of Cornell University 40
Large-scale testing (Phase 3)UnknownNCT04247945
What this trial is testing

Co-transplantation of MSC in the Setting of Allo-HSCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Fujian Medical University 120
Not applicableStudy completedNCT04412811
What this trial is testing

Prospective Survey of CMV, Herpesviruses Infections and Diseases in Allo-HSCT

Who this might be right for
Hematologic DiseasesStem Cell Transplant ComplicationsCytomegalovirus Viremia+1 more
Gruppo Italiano Trapianto di Midollo Osseo 1,310
Not applicableLooking for participantsNCT07183878
What this trial is testing

Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)

Who this might be right for
Acute Myeloid LeukemiaHigh-Risk Acute Myeloid LeukemiaMyelodysplastic Syndromes+1 more
First Affiliated Hospital of Zhejiang University 138
Early research (Phase 1)Study completedNCT00350818
What this trial is testing

Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT)

Who this might be right for
Myelodysplastic SyndromeLeukemia
M.D. Anderson Cancer Center 90
Next Page